← Back to Search

Procedure

Magnetic Device for Lagophthalmos

N/A
Recruiting
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 3 years
Awards & highlights

Summary

"This trial investigates a new treatment for paralytic lagophthalmos, a condition that can lead to corneal ulceration and potentially blindness. The study shows promising results using externally affixed magnets

Who is the study for?
This trial is for adults aged 18-80 with lagophthalmos, a condition where the eyelid cannot close properly, leading to corneal exposure. It's also open to those who've recently had a corneal abrasion without infection. People with allergies to adhesives or tape, metal fragments in their eye from past activities like welding, or current eye infections can't participate.
What is being tested?
The study is testing a new temporary magnetic system (MST) designed to help control eyelid position and treat paralytic lagophthalmos which can cause corneal ulcers and potentially blindness. The device uses improved magnetic technology that has shown promise in preliminary studies.
What are the potential side effects?
Potential side effects may include discomfort at the site of magnet application, skin irritation due to the adhesive used for keeping magnets in place, and possible interference with electronic devices if they come into close proximity with the magnets.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with success of a temporary magnetic system for tarsorrhaphy

Trial Design

1Treatment groups
Experimental Treatment
Group I: Assess the performance of this novel eyelid closure device in vivoExperimental Treatment1 Intervention
The primary goal of this study is to determine the feasibility and success of a temporary magnetic system for tarsorrhaphy (MST) to provide adequate closure of the eyes for ultimate use in conditions causing lagophthalmos (a disorder in eyelid closure). In this disorder, people are unable to sufficiently cover their cornea (the front of the eye), which can lead to dryness, infection, scarring and even blindness. Current therapies are invasive, involving local anesthesia and surgeries, and have a negative cosmetic impact.

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
632 Previous Clinical Trials
1,567,690 Total Patients Enrolled
1 Trials studying Corneal Ulcer
38 Patients Enrolled for Corneal Ulcer
~7 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top